What is irinotecan, and what does the “SPC” mean?
“In SPC” usually refers to the Summary of Product Characteristics (SPC) for a specific irinotecan-containing medicine. The SPC is the official, regulator-approved document that describes how the drug is indicated to be used, including dosing, administration, contraindications, warnings, and the main adverse reactions.
How do you find the right irinotecan SPC for your country and brand?
Irinotecan products differ by:
- Country/region (EMA/EU vs. national regulators)
- Strengths and formulation (for example, different vial concentrations or infusion presentations)
- Brand name and marketing authorization holder
To get the correct SPC, you typically need the exact product name (including strength) and the country/authority whose label you want (for example, an EU SPC vs. another market).
What key sections are in the irinotecan SPC?
Most irinotecan SPCs include sections such as:
- Therapeutic indications
- Posology and method of administration (dose, scheduling, infusion guidance)
- Contraindications
- Special warnings and precautions (including risks like severe diarrhea and blood count suppression)
- Interactions
- Pregnancy, lactation, and fertility information
- Adverse reactions
- Overdose guidance
- Pharmaceutical particulars (how it’s supplied, storage, and excipients)
If you meant “irinotecan SPC dosing,” what does it usually specify?
The SPC dosing for irinotecan generally covers:
- Recommended dosing schedules (often described by treatment line and in combination vs monotherapy)
- Dose adjustments based on tolerance and adverse reactions (especially diarrhea and neutropenia)
- Guidance for infusion and how the medicine should be handled and administered
Because dosing details are product- and indication-specific, you need the exact SPC text for the irinotecan brand and the jurisdiction you’re using.
Can you share which exact irinotecan SPC you want?
Reply with any of the following so I can point you to the right SPC content:
- Country/region (e.g., UK, EU, US, etc.)
- Brand name (or strength, such as “irinotecan … mg/mL”)
- Whether it’s irinotecan hydrochloride and the formulation (injection/infusion)
- If you have it, the exact SPC wording or a link/document name
Patents and exclusivity (if your question is actually about a specific irinotecan product’s SPC labeling)
If you’re asking about an SPC in the patent context (often confused with “SPC” in European IP), tell me which patent/product—SPC can also mean “Supplementary Protection Certificate” in Europe. DrugPatentWatch.com can help identify patent/SPC status for specific medicines: https://www.drugpatentwatch.com/ (no specific irinotecan product provided yet).
---
Sources
No sources were cited because no specific irinotecan product, country, or “SPC” type (Summary vs Supplementary Protection Certificate) was provided.